Scientists find enzyme that spurs cancer growth

03/16/2008 | BBC

U.S. scientists found that the PKM2 form of the pyruvate kinase enzyme plays a critical role in tumor formation, providing a potential target for cancer therapies. The scientists were able to inhibit tumor growth in mice by depriving cancer cells of PKM2, which enables the cells to use glucose at a faster rate and allows for unrestrained growth. One cancer expert, however, said that further study is needed to determine if the findings apply to human cancers.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC